Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Vale S.A.

Start price
Target price
Perf. (%)
€18.20
05.06.21
€28.00
05.06.22
-3.10%
06.06.22

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Rising EBIT margin expected
Probably not worthwhile Investment
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€114.10
07.01.22
€130.00
07.01.23
-63.63%
05.06.22

Could be worthwhile Investment >10% per year
buy
Criteo S.A. ADR

Start price
Target price
Perf. (%)
€34.20
04.06.21
€36.00
04.06.22
-30.41%
05.06.22

Could be worthwhile Investment >10% per year
buy
KKO International

Start price
Target price
Perf. (%)
€0.15
04.06.21
€0.20
04.06.22
-0.54%
05.06.22

Could be worthwhile Investment >10% per year
buy
Temenos AG ADR

Start price
Target price
Perf. (%)
€127.00
04.06.21
€125.00
04.06.22
-31.10%
05.06.22

Could be worthwhile Investment >10% per year
buy
Capital Bancorp Inc

Start price
Target price
Perf. (%)
€20.20
04.06.21
€20.00
04.06.22
5.94%
05.06.22

Could be worthwhile Investment >10% per year
buy
Bitcoin

Start price
Target price
Perf. (%)
€30,421
04.06.21
€35,000
04.06.22
-8.41%
05.06.22

buy
Canadian Solar Inc.

Start price
Target price
Perf. (%)
€29.55
31.05.22
€32.00
31.05.23
4.91%
04.06.22

EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
High dividend yield expected
Charles Schwab Corp.

Start price
Target price
Perf. (%)
€57.70
23.07.21
-
23.07.22
15.23%
04.06.22

negative Cash Flow expected
Revenue decline/stagnation expected
High valuation
Low dividend yield expected
buy
Geratherm Medical AG

Start price
Target price
Perf. (%)
€9.46
03.10.21
-
03.10.22
-10.78%
04.06.22

Could be very worthwhile Investment >20% year
buy
Saint Gobain S.A.

Start price
Target price
Perf. (%)
€57.60
03.06.21
€60.00
03.06.22
-2.97%
04.06.22

Could be worthwhile Investment >10% per year
buy
Tritax Eurobox

Start price
Target price
Perf. (%)
€1.25
03.06.21
€2.00
03.06.22
-12.80%
04.06.22

Could be worthwhile Investment >10% per year
buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€91.61
03.06.21
€115.00
03.06.22
34.21%
04.06.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
positive Cash Flow expected
buy
Sunpower Corp.

Start price
Target price
Perf. (%)
€19.78
03.06.21
-
03.06.22
-11.95%
04.06.22

Could be very worthwhile Investment >20% year
Sustainability is important
Small cyclical dependencies
Future proof or reliable business model
buy
Gazprom ADR

Start price
Target price
Perf. (%)
€6.18
06.08.19
€17.00
04.06.22
-36.18%
04.06.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Paypal Holdings Inc

Start price
Target price
Perf. (%)
€111.00
06.02.22
-
06.02.25
-27.25%
03.06.22

Could be worthwhile Investment >10% per year
buy
Freelance.com

Start price
Target price
Perf. (%)
€5.66
19.06.21
€7.00
02.06.22
29.33%
03.06.22

Could be worthwhile Investment >10% per year
buy
Tesla Inc

Start price
Target price
Perf. (%)
€165.58
03.06.21
€170.00
03.06.22
46.15%
03.06.22

buy
Advanced Micro Devices Inc.

Start price
Target price
Perf. (%)
€67.39
03.06.21
€150.00
03.06.22
50.59%
03.06.22

buy
Mobotix AG

Start price
Target price
Perf. (%)
€5.95
02.06.21
€7.00
02.06.22
-31.76%
03.06.22

Could be worthwhile Investment >10% per year
buy
Atos SE

Start price
Target price
Perf. (%)
€42.50
12.11.21
€44.00
12.11.22
-38.71%
02.06.22

Could be worthwhile Investment >10% per year
buy
Noxxon Pharma N.v.

Start price
Target price
Perf. (%)
€0.24
12.11.21
€0.38
12.11.22
-51.77%
02.06.22

Could be worthwhile Investment >10% per year
buy
Citigroup Inc.

Start price
Target price
Perf. (%)
€58.95
12.09.21
-
12.09.22
-17.26%
02.06.22

Revenue growth >5% per year expected
EBIT growth >5% per year expected
High dividend yield expected
buy
Bone Therapeutics S.A.

Start price
Target price
Perf. (%)
€1.56
10.09.21
€2.00
10.09.22
-82.43%
02.06.22

Could be worthwhile Investment >10% per year
Protalix Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.76
04.04.22
€0.000
04.04.23
-35.27%
02.06.22

Could be worthwhile Investment >10% per year
Revenue decline/stagnation expected
EBIT decline > 20% expected
overvalued